Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multicenter, Real-World Clinical Evaluation of Alemtuzumab and Anti-Thymocyte Globulin for Severe Acute T Cell-Mediated Kidney Transplant Rejection.
van Vugt LK, Tegzess E, van der Zwan M, Clahsen-van Groningen MC, de Winter BCM, Vart P, Reinders MEJ, Sanders JSF, Berger SP, Hesselink DA. van Vugt LK, et al. Among authors: de winter bcm. Clin Transplant. 2024 Dec;38(12):e70046. doi: 10.1111/ctr.70046. Clin Transplant. 2024. PMID: 39636744 Free PMC article.
Association Between the Intracellular Tacrolimus Concentration in CD3 + T Lymphocytes and CD14 + Monocytes and Acute Kidney Transplant Rejection.
Udomkarnjananun S, Francke MI, Dieterich M, van de Velde D, Verhoeven JGHP, Boer K, Clahsen-Van Groningen MC, De Winter BCM, Baan CC, Hesselink DA. Udomkarnjananun S, et al. Among authors: de winter bcm. Ther Drug Monit. 2022 Oct 1;44(5):625-632. doi: 10.1097/FTD.0000000000000982. Ther Drug Monit. 2022. PMID: 35358111
Investigational drugs for the treatment of kidney transplant rejection.
van Vugt LK, Schagen MR, de Weerd A, Reinders ME, de Winter BC, Hesselink DA. van Vugt LK, et al. Expert Opin Investig Drugs. 2022 Oct;31(10):1087-1100. doi: 10.1080/13543784.2022.2130751. Epub 2022 Oct 7. Expert Opin Investig Drugs. 2022. PMID: 36175360 Free article. Review.
Personalized immunosuppression in elderly renal transplant recipients.
Peeters LEJ, Andrews LM, Hesselink DA, de Winter BCM, van Gelder T. Peeters LEJ, et al. Among authors: de winter bcm. Pharmacol Res. 2018 Apr;130:303-307. doi: 10.1016/j.phrs.2018.02.031. Epub 2018 Mar 6. Pharmacol Res. 2018. PMID: 29501679 Free article. Review.
Avoiding Tacrolimus Underexposure and Overexposure with a Dosing Algorithm for Renal Transplant Recipients: A Single Arm Prospective Intervention Trial.
Francke MI, Andrews LM, Le HL, van de Wetering J, Clahsen-van Groningen MC, van Gelder T, van Schaik RHN, van der Holt B, de Winter BCM, Hesselink DA. Francke MI, et al. Among authors: de winter bcm. Clin Pharmacol Ther. 2021 Jul;110(1):169-178. doi: 10.1002/cpt.2163. Epub 2021 Feb 23. Clin Pharmacol Ther. 2021. PMID: 33452682 Free PMC article.
Monitoring intracellular tacrolimus concentrations and its relationship with rejection in the early phase after renal transplantation.
Francke MI, Andrews LM, Lan Le H, van de Velde D, Dieterich M, Udomkarnjananun S, Clahsen-van Groningen MC, Baan CC, van Gelder T, de Winter BCM, Hesselink DA. Francke MI, et al. Among authors: de winter bcm. Clin Biochem. 2022 Mar;101:9-15. doi: 10.1016/j.clinbiochem.2021.12.002. Epub 2021 Dec 8. Clin Biochem. 2022. PMID: 34890583 Free article.
122 results